Technologies & Platforms

Start Your Project Now!

Please note: Our products and services are not intended to be used directly in diagnostic or therapeutic procedures.

Here's how you can reach us...

Tel:
Email:

Viral Vector Platforms for Nucleic Acid Drug Delivery

Inquiry

CD Formulation's viral vector platform is committed to delivering innovative solutions for the efficient delivery of nucleic acid drugs and gene therapies. Utilizing advanced genetic engineering techniques and bioinformatics analysis, we optimize the safety, stability, and delivery efficiency of our viral vectors, ensuring that our customers have access to a reliable and effective drug delivery system.

About Viral Vectors for Nucleic Acid Drug Delivery

Viral vectors are essential tools for the delivery of nucleic acid-based drugs and are extensively utilized in gene therapy and vaccine development. Viral vector packaging is primarily categorized into three main groups: lentivirus (LV), adenovirus (ADV), and adeno-associated virus (AAV). Among these, lentivirus is a modified viral vector derived from the human immunodeficiency virus (HIV), which is classified as a retrovirus. The adeno-associated virus features an icosahedral protein capsid with a diameter of approximately 26 nm and contains a single-stranded DNA genome of about 4.7 kb. In contrast, adenovirus is a non-enveloped virus with a diameter of approximately 90-100 nm, known for its broad range of cellular and tissue infectivity. Adenovirus vectors can accommodate large gene fragments, with a capacity of 7-8 kb.

Fig.1 Advantages of viral vectors. (CD Formulation)

Applications of Viral Vectors

Tumor Diseases

The modification of T-cells using viral vectors can effectively target and eliminate tumors. Viruses such as herpes simplex virus (HSV) possess natural tumorigenicity and can selectively destroy cancer cells.

Rare Diseases

Most rare diseases stem from genetic mutations, and gene therapy has the potential to provide a lifelong cure.

Infectious Diseases

Since adenoviral vectors can infect respiratory and intestinal cells, they can promote immunization via the mucosal route and elicit both mucosal and systemic immune responses in the body.

Neurological Diseases

Some viral vectors are capable of crossing the blood-brain barrier to specifically target brain tissue.

Metabolic Diseases

Most naturally occurring adeno-associated viruses (AAV) exhibit a high affinity for the liver, making them suitable for in vivo gene therapy aimed at modifying metabolic processes.

Types of Viral Vector Drug Delivery Platforms

By harnessing the natural infection mechanisms of viruses, therapeutic genes or drugs can be precisely targeted and delivered to specific cells. Viral vector platforms encompass various types of viral vectors, each possessing distinct properties and application scenarios.

Adeno-Ass Virus Vector Platforms

Adenovirus Vector Platforms

Lentiviral Vector Platforms

Lysovirus Vector Platforms

Poxvirus Vector Platforms

Viral Vector Optimization Platforms

CD Formulation's viral vector optimization platform is committed to enhancing the efficiency and safety of gene therapy and drug delivery. Utilizing advanced molecular biology tools, our platform can precisely modify the genomes of viral vectors to improve their specificity and stability.

Genetic Modification and Optimization

Viral vectors are genetically engineered to enhance their targeting capabilities, reduce immunogenicity, and improve their effectiveness in delivering genes.

Items	Descriptions
Genetic Coding Modifications	Modifying the gene sequence of viral capsid proteins to improve targeting to specific cells or tissues. This can be achieved by inserting cell-specific ligands or antibody fragments.
Insertion of Regulatory Elements	The introduction of potent promoter and enhancer elements enhances the efficiency of target gene expression. Design regulatory elements tailored to therapeutic needs to achieve spatiotemporal control of gene expression.
Splice Site Modification	Optimize the splice site of the viral genome to reduce the number of splice mutations that may cause adverse reactions.

Viral Vector Modification

The use of chemical modification and nanotechnology to improve the stability of viral vectors, prevent immune clearance, and enhance targeting.

Items	Descriptions
PEGylation	Linking polyethylene glycol (PEG) to the surface of the virus increases its circulation time in the bloodstream and reduces its recognition and clearance by the immune system.
Nanoparticle Encapsulation	Encapsulating the virus in biocompatible nanoparticles leverages nanocarriers that offer protection, targeted delivery, and controlled release.
Surface Peptide or Antibody Modification	The attachment of specific cell surface peptides or antibodies to the virus's surface enhances its ability to target particular cells or tissues.

Highlights of Viral Vector Drug Delivery Platforms

Optimized viral vectors possess efficient gene and drug delivery capabilities, allowing them to precisely target specific cells or tissues.
Strict quality control and optimized design ensure the safety and biocompatibility of viral vectors, minimizing immune responses and side effects.
Viral vectors are customized to meet client specifications, and our comprehensive service - from design to production - ensures both flexibility and efficiency in our solutions.

Custom Nucleic Acid Formulation Carrier Services

CD Formulation's viral vector platform offers specialized custom viral development services tailored to address a wide range of drug delivery and gene therapy requirements.

Custom Viral Vector Services

Our viral vector custom development service offers comprehensive support, encompassing design optimization, manufacturing, and quality control. We specialize in the custom development of various viral types, such as adeno-associated virus and adenovirus, to ensure efficient and safe gene delivery and expression. Additionally, our platform provides in-depth technical consultation and ongoing support to tailor the optimal solution for each project.

Publication Data

Technology: Viral vector platform for drug delivery

Journal: Science of The Total Environment

IF: 10.754

Published: 2021

Results:

Nanoparticles have emerged as a new tool that can be used directly or indirectly to fight deadly bacterial infections and thus overcome antibiotic resistance. Although nanoparticles are being used in the pharmaceutical industry, there have been concerns about their toxicity to human health due to the presence of well-known toxic chemicals (e.g., sodium borohydride/potassium borohydride), making their use very dangerous for eukaryotic cells. A variety of nanoparticle-based approaches are being used to combat bacterial infections, which provides important insights into the design of elements that play a key role in antimicrobial nanotherapeutics. The aim of this paper is to review the practical knowledge about nanoparticle products for the treatment of antibiotic resistance and the possibility of replacing antibiotics in the treatment of multidrug resistant bacterial infections.

Fig.2 Different nanoparticle types are used for drug delivery Fig.2 Nanoparticles used as drug delivery systems. (Anand U, et al., 2022)

CD Formulation's viral vector platform not only provides a diverse array of viral vectors but also emphasizes optimized design and technological innovation to ensure efficient and precise drug delivery. If you are interested in our platform, please contact us.

References

Anand U, Carpena M, Kowalska-Góralska M, et al. Safer plant-based nanoparticles for combating antibiotic resistance in bacteria: A comprehensive review on its potential applications, recent advances, and future perspective. Sci. Total Environt. 2022, 821: 153472.

How It Works

STEP 1

Submit a service request describing your specific research or development need.

STEP 2

We'll email you to provide your quote and confirm order details if applicable.

STEP 3

Execute the project with real-time communication, and deliver the final report promptly.

Related Services